Everything will be "revealed" when the Ts & Cs get announced. If, if the Linkedin infos are correct and get confirmed on Monday then Hopper has no excuse for raising below 1c. A world first CAR-T showing a positive response when attacking a solid cancer, and not just a solid, a gastric type of the worst kind, then he MUST and CAN demand a lot more for that. If he gets it done and dumps Lind then I won't mind paying 1.5c to re-enter as there would be still an enormous upside.
ALA still managed to sell its pre-clinical iNKT for $120m this week, nothing clinical, not even an IND. Hopper must lift up his game, money is out there especially when being on the score board.
If Dr Bec can get a grant, Hopper must be able to get some funding.
CHM Price at posting:
0.7¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)